# abrdn Gold ETF Trust: financial statements, quarterly

SGOL · NYSE · CIK 1450923 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sgol.md) · [Financials](/companies/sgol/financials.md) · [Filings](/companies/sgol/filings.md) · [Insiders](/companies/sgol/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sgol/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(58.4)](/filings/0001999371-24-014544.md) | [283 d](/filings/0001999371-26-004974.md) | [177](/filings/0001999371-25-005700.md) | [154](/filings/0001999371-25-010847.md) | [411](/filings/0001999371-25-017265.md) | [(31.5) d](/filings/0001999371-26-004974.md) | [738](/filings/0001999371-26-010359.md) | [255](/filings/0001999371-26-017412.md) | [872](/filings/0001999371-25-017265.md) | [789 d](/filings/0001999371-26-004974.md) | [497](/filings/0001999371-26-010359.md) | [(989)](/filings/0001999371-26-017412.md) |
| Basic EPS | $ per share | [(0.40)](/filings/0001999371-24-014544.md) | not reported | [1.27](/filings/0001999371-25-005700.md) | [1.10](/filings/0001999371-25-010847.md) | [2.84](/filings/0001999371-25-017265.md) | not reported | [4.82](/filings/0001999371-26-010359.md) | [1.57](/filings/0001999371-26-017412.md) | [5.24](/filings/0001999371-25-017265.md) | not reported | [2.75](/filings/0001999371-26-010359.md) | [(5.54)](/filings/0001999371-26-017412.md) |

- Gross profit: not reported
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,586](/filings/0001839882-23-030157.md) | [2,827](/filings/0001839882-25-012451.md) | [2,940](/filings/0001999371-24-005861.md) | [3,143](/filings/0001999371-24-009834.md) | [3,738](/filings/0001999371-24-014544.md) | [3,757](/filings/0001999371-26-004974.md) | [4,807](/filings/0001999371-25-005700.md) | [5,168](/filings/0001999371-25-010847.md) | [6,267](/filings/0001999371-25-017265.md) | [7,334](/filings/0001999371-26-017412.md) | [7,868](/filings/0001999371-26-010359.md) | [6,744](/filings/0001999371-26-017412.md) |
| Total liabilities | $m | [3.9](/filings/0001839882-23-030157.md) | [0.4](/filings/0001839882-25-012451.md) | [0.4](/filings/0001999371-24-005861.md) | [0.4](/filings/0001999371-24-009834.md) | [0.5](/filings/0001999371-24-014544.md) | [0.5](/filings/0001999371-26-004974.md) | [0.7](/filings/0001999371-25-005700.md) | [0.7](/filings/0001999371-25-010847.md) | [26.4](/filings/0001999371-25-017265.md) | [1.1](/filings/0001999371-26-017412.md) | [1.1](/filings/0001999371-26-010359.md) | [0.9](/filings/0001999371-26-017412.md) |
| Shareholders' equity | $m | [2,582](/filings/0001999371-24-014544.md) | [2,826](/filings/0001999371-26-004974.md) | [2,940](/filings/0001999371-25-010847.md) | [3,142](/filings/0001999371-25-017265.md) | [3,737](/filings/0001999371-25-017265.md) | [3,756](/filings/0001999371-26-017412.md) | [4,807](/filings/0001999371-26-017412.md) | [5,168](/filings/0001999371-26-017412.md) | [6,240](/filings/0001999371-25-017265.md) | [7,333](/filings/0001999371-26-017412.md) | [7,867](/filings/0001999371-26-017412.md) | [6,743](/filings/0001999371-26-017412.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2011-03-31) | Q2 FY2011 (2011-06-30) | Q3 FY2011 (2011-09-30) | Q4 FY2011 (2011-12-31) | Q1 FY2012 (2012-03-31) | Q2 FY2012 (2012-06-30) | Q3 FY2012 (2012-09-30) | Q4 FY2012 (2012-12-31) | Q1 FY2013 (2013-03-31) | Q2 FY2013 (2013-06-30) | Q3 FY2013 (2013-09-30) | Q4 FY2013 (2013-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.0](/filings/0000930413-12-002979.md) | [0.0](/filings/0000930413-12-004462.md) | [0.0](/filings/0001450923-12-000003.md) | [0.0 d](/filings/0001450923-14-000003.md) | [0.0](/filings/0001450923-13-000004.md) | [0.0](/filings/0001450923-13-000022.md) | [0.0](/filings/0001450923-13-000028.md) | [0.0 d](/filings/0001450923-15-000002.md) | [0.0](/filings/0001450923-14-000014.md) | [0.0](/filings/0001450923-14-000019.md) | [0.0](/filings/0001450923-14-000021.md) | [0.0 d](/filings/0001450923-16-000027.md) |
| Share repurchases | $m | [13.2](/filings/0000930413-12-002979.md) | [0.0](/filings/0000930413-12-004462.md) | [42.2](/filings/0001450923-12-000003.md) | [15.9 d](/filings/0001450923-14-000003.md) | [24.7](/filings/0001450923-13-000004.md) | [16.3](/filings/0001450923-13-000022.md) | [31.9](/filings/0001450923-13-000028.md) | [25.5 d](/filings/0001450923-15-000002.md) | [16.4](/filings/0001450923-14-000014.md) | [246](/filings/0001450923-14-000019.md) | [45.2](/filings/0001450923-14-000021.md) | [111 d](/filings/0001450923-16-000027.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 175,500,000 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001999371-26-017412.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.